1. Home
  2. EVO vs GDRX Comparison

EVO vs GDRX Comparison

Compare EVO & GDRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Evotec SE

EVO

Evotec SE

HOLD

Current Price

$2.73

Market Cap

934.1M

Sector

Health Care

ML Signal

HOLD

Logo GoodRx Holdings Inc.

GDRX

GoodRx Holdings Inc.

HOLD

Current Price

$2.51

Market Cap

883.9M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
EVO
GDRX
Founded
1993
2011
Country
Germany
United States
Employees
4553
697
Industry
Biotechnology: Pharmaceutical Preparations
Retail: Computer Software & Peripheral Equipment
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
934.1M
883.9M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
EVO
GDRX
Price
$2.73
$2.51
Analyst Decision
Strong Buy
Buy
Analyst Count
1
9
Target Price
$7.00
$3.66
AVG Volume (30 Days)
95.9K
1.6M
Earning Date
04-08-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
125.00
EPS
N/A
N/A
Revenue
N/A
$796,853,000.00
Revenue This Year
$1.37
N/A
Revenue Next Year
$10.05
$5.38
P/E Ratio
N/A
$28.94
Revenue Growth
N/A
0.57
52 Week Low
$2.31
$1.77
52 Week High
$4.80
$5.61

Technical Indicators

Market Signals
Indicator
EVO
GDRX
Relative Strength Index (RSI) 41.07 51.96
Support Level $2.32 $2.15
Resistance Level $3.78 $2.95
Average True Range (ATR) 0.09 0.17
MACD -0.06 -0.02
Stochastic Oscillator 19.16 33.56

Price Performance

Historical Comparison
EVO
GDRX

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

About GDRX GoodRx Holdings Inc.

GoodRx Holdings Inc is a consumer-focused digital healthcare platform that aims to lower the cost of healthcare in the United States. It operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and provides access to negotiated prices through codes that can be used to save money on prescriptions across the United States. GoodRx generates revenue from core business from pharmacy benefit managers (PBMs) that manage formularies and prescription transactions including establishing pricing between consumers and pharmacies. It also offers various healthcare products and services, including pharma manufacturer solutions, subscriptions, and telehealth services.

Share on Social Networks: